Phase II randomized window of opportunity trial evaluating cytotoxic and immunomodulatory effects of intratumoral INT230-6 in early stage breast cancer: The INVINCIBLE trial. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pond, Gregory
  • Spears, Melanie
  • Hopkins, Megan
  • Keyhanian, Kianoosh
  • Robertson, Susan
  • Liao, Linda
  • Talebian, Vida
  • Awan, Arif Ali
  • Pond, Gregory Russell
  • Bartlett, John
  • Bender, Lewis H
  • Walters, Ian B
  • Lopez-Ozuna, Vanessa
  • Arnaout, Angel

publication date

  • June 1, 2023